Quote: The future of US cardiovascular mortality, costs, and quality of life

Ankur Pandya, Thomas A. Gaziano, Milton C. Weinstein, and David Cutler in Health Affairs:

…continued improvements in cardiovascular disease treatment and declining smoking rates will not outweigh the influence of increasing population age and obesity on cardiovascular disease risk. Given an aging population, an obesity epidemic, and declining mortality from the disease, the United States should expect to see a sharp rise in the health care costs, disability, and reductions in quality of life associated with increased prevalence of cardiovascular disease. Policies that target the treatment of high blood pressure and cholesterol and the reduction of obesity will be necessary to curb the imminent spike in cardiovascular disease prevalence.


Hidden information below


* indicates required
Email Format